The leaflet provides dosage, indications, contraindications, side effects, and storage information for Acetazolamide tablets by Yanjing Pharmaceutical.
This leaflet describes Acetazolamide tablets, a carbonic anhydrase inhibitor used to lower intra‑ocular pressure in various types of glaucoma. It lists the composition, physical description, approved indications, and recommended dosage regimens for adults, children, and special populations.
Safety information includes common adverse reactions, contraindications such as severe liver or kidney dysfunction, precautions for pregnancy, lactation, and drug interactions, as well as proper storage and packaging details. This manual is written in Chinese.
| Strength per tablet | 0.25 g |
|---|---|
| Molecular formula | C4H6N4O3S2 |
| Molecular weight | 222.25 g·mol⁻¹ |
| Packaging | Plastic bottle, 100 tablets per bottle |
| Shelf life | 36 months |
The usual adult dose is 250 mg (one tablet) taken 1–3 times daily, typically twice a day.
Common side effects include limb numbness and tingling, fatigue, weight loss, drowsiness, depression, and gastrointestinal upset such as nausea and diarrhea.
Store the tablets in a light‑proof, sealed container.